Managing Your Practices Myopia Integration

Managing Your Practices Myopia Integration

xr:d:DAGCKAaKO_E:3,j:575759436167122407,t:24041200

Insight Magazine With an abundance of evidence, diagnostics and treatments, the bar has arguably never been lower for practices to incorporate myopia control. In fact, some contend there is a diminishing list of reasons for Optometrists not to practice some form of management. Insight speaks to Mark Hinds, Kevin Trac and Jenkin Yau about their… Continue reading Managing Your Practices Myopia Integration

Efficacy and safety of AZR-MD-001 selenium sulfide ophthalmic ointment in adults with meibomian gland dysfunction: A vehicle-controlled, randomized clinical trial

The Ocular Surface Volume 29, July 2023, Pages 537-546 Stephanie L. Watson, Lyndon W. Jones, Fiona Stapleton, Mark Hinds, Alison Ng, Jacqueline Tan, Yair Alster, Charles Bosworth, Omer Rafaeli, Venita DePuy, The CELESTIAL STUDY Group Over the past few years our own, Mark Hinds, with his team at Ophthalmic Trials Australia (www.ot-au.com) have been involved in the multi-centered investigation into the efficacy and safety of selenium sulfide ointment in the setting of meibomian gland dysfunction (MGD)… Continue reading Efficacy and safety of AZR-MD-001 selenium sulfide ophthalmic ointment in adults with meibomian gland dysfunction: A vehicle-controlled, randomized clinical trial

MiYOSMART Spectacle Lenses for Myopia Control

The MiYOSMART spectacle lenses have been found to significantly reduce the progression of myopia and axial elongation in children in the UK, as compared to data from untreated myopes. The study looked at the change in spherical equivalent refraction (SER) and axial length (AL) over a period of 12 months in 87 children between the… Continue reading MiYOSMART Spectacle Lenses for Myopia Control

Myopia in Australian kids – an easy read

Myopia, commonly known as nearsightedness, is a growing concern in Australia, especially in children. Myopia occurs when the eye is longer than normal, causing light to focus in front of the retina instead of on it, leading to blurred vision. This can lead to a range of problems, such as difficulty reading or seeing distant… Continue reading Myopia in Australian kids – an easy read

Risk factors for fast and slow myopia progression in a randomized controlled trial of 0.01% atropine eye drops

ARVO Abstract Number: 812 – C0495 AuthorBlock: Matilda Biba1, Gareth Lingham1, Emmanuel Kobia-Acquah1, Ian Flitcroft1,2, James Loughman1 1Centre for Eye Research Ireland (CERI), Technological University Dublin, Dublin, Dublin, Ireland; 2Ophthalmology, Children’s Health Ireland at Temple Street, Dublin, Dublin, Ireland; Summary of paper : Myopia, also known as near sightedness, is a condition where a person can see nearby… Continue reading Risk factors for fast and slow myopia progression in a randomized controlled trial of 0.01% atropine eye drops

The Association for Research in Vision and Ophthalmology (ARVO 2023) Publication

AZR-MD-001 restores gland gunction and improves signs and ocular symptoms of mebomian gland dysfunction (MGD) Posterboard#: B0072 Abstract Number: 5175 – B0072 AuthorBlock: Preeya Gupta1,2, Laura Elizabeth Downie3, Mark Hinds4, Yair Alster5, Charles Bosworth5 1Ophthalmology, Triangle Eye Consultants, Raleigh, North Carolina, United States; 2Ophthalmology, Tulane University, New Orleans, Louisiana, United States; 3Optometry and Vision Science, The University of Melbourne, Melbourne,… Continue reading The Association for Research in Vision and Ophthalmology (ARVO 2023) Publication

The Association for Research in Vision and Ophthalmology (ARVO 2023) – Publication.

AZR-MD-001 efficacy in resolving the signs and associated symptoms of meibomian gland dysfunction (MGD) in a phase 2 trial: responder status analysis Posterboard#: B0026 Abstract Number: 5129 – B0026 AuthorBlock: Lisa Nijm1,2, Jennifer P. Craig3, Mark Hinds4, Yair Alster5, Charles Bosworth5 1Ophthalmology, Warrenville EyeCare & LASIK, Chicago, Illinois, United States; 2Ophthalmology, University of illinois Eye and Ear Infirmary, Chicago,… Continue reading The Association for Research in Vision and Ophthalmology (ARVO 2023) – Publication.

Atropine Dosage in Australian Population

Atropine Dosage in Australian Population – April 2023 – Myopia Profile Update AbstractTitle: Low-concentration atropine eyedrops for myopia control in a multi-racial cohort of Australian children: A randomised clinical trialAuthors: Samantha Sze-Yee Lee, Gareth Lingham, Magdalena Blaszkowska, Paul G Sanfilippo, Adrian Koay, Maria Franchina, Audrey Chia, James Loughman, Daniel Ian Flitcroft, Christopher J Hammond, Augusto… Continue reading Atropine Dosage in Australian Population

Mark Presents at Australian Vision Convention 2019

Mark presented at the Australian Vision Convention on his thoughts on fitting the complex cornea. He illustrated the use of SynergEyes hybrid contact lenses in the space of patients with and with out astigmatism, presbyopia and keratoconus. More specifically, keratoconus in patients with and without preceding corneal refractive surgery. Leading on from that fitting more… Continue reading Mark Presents at Australian Vision Convention 2019

QUT Insights to Succeeding in Optometry

Mark was honoured to be part of the promotional and educational package for current and future optometry students at Queensland University of Optometry. He has been part of the teaching program at QUT for 16 years in the field of complex contact lenses. He had a great time and hopes that his insights into contact… Continue reading QUT Insights to Succeeding in Optometry